Suchergebnisse - "Burgenske, Danielle M."

PubPharm (23)

1

Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization

enthalten in: Science translational medicine | 2024

von Chen, J. | Laverty, D. | Talele, S. | +16

2

Differential distribution of the DNA-PKcs inhibitor peposertib selectively radiosensitizes patient-derived melanoma brain metastasis xenografts

enthalten in: Molecular cancer therapeutics | 2024

von Ji, J. | Dragojevic, S. | Callaghan, C. | +17

3

Delivery versus Potency in Treating Brain Tumors : BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma

enthalten in: Molecular cancer therapeutics | 2024

von Zhang, W. | Vaubel, R. | Oh, J. | +7

4

WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models

enthalten in: Neuro-oncology advances | 2023

von Conage-Pough, J. | Stopka, S. | Oh, J. | +17

5

Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390 : Implications for the Treatment of Brain Tumors

enthalten in: The Journal of pharmacology and experimental therapeutics | 2022

von Talele, S. | Zhang, W. | Chen, J. | +4

6

Single-cell based elucidation of molecularly-distinct glioblastoma states and drug sensitivity

enthalten in: bioRxiv.org | 2022

von Ding, H. | Burgenske, D. | Zhao, W. | +18

7

RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma

enthalten in: Neuro-oncology | 2022

von Mladek, A. | Yan, H. | Tian, S. | +13

8

Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases

enthalten in: The Journal of pharmacology and experimental therapeutics | 2022

von Talele, S. | Zhang, W. | Oh, J. | +5

ErratumIn: J Pharmacol Exp Ther. 2022 Dec;383(3):251. - PMID 36396351

9

Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy

enthalten in: Science advances | 2022

von Ng, T. | Hu, H. | Kronister, S. | +23

10

Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin-a novel tumor checkpoint controller targeting microtubules

enthalten in: Neuro-oncology | 2022

von Burgenske, D. | Talele, S. | Pokorny, J. | +19

CommentIn: Neuro Oncol. 2021 Nov 27;:. - PMID 34850193